Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04674228 · ClinicalTrials.gov registry record
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
A clinical trial of Familial Adenomatous Polyposis, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 42
- Enrollment target
- 2
- Study locations
NCT04674228: Completed study of Familial Adenomatous Polyposis, sponsored by National Cancer Institute (NCI).
NCT04674228 is a study of Familial Adenomatous Polyposis that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 42 participants, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04674228, a study of Familial Adenomatous Polyposis, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyposis disease burden after discontinuation of weekly erlotinib.
Conditions Studied
Interventions
- OTHER Electronic Health Record Review
Study Locations (2)
Minnesota
- Mayo Clinic in Rochester - Rochester
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-07 |
| Est. Completion | 2022-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04674228
The ClinicalTrials.gov registry entry for NCT04674228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 10 other Familial Adenomatous Polyposis trials with a reported enrollment target (83% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Familial Adenomatous Polyposis appearing as the primary indexed condition, and to 1 intervention - of which Electronic Health Record Review is the first listed.
NCT04674228 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Texas.
Frequently Asked Questions
What is clinical trial NCT04674228 about?
NCT04674228 is a clinical study titled "Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01". This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyp...
What is the current status of trial NCT04674228?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2021-05-07. Estimated completion is 2022-05-17.
What conditions does trial NCT04674228 study?
This clinical trial studies the following conditions: Familial Adenomatous Polyposis.
What interventions are being tested in trial NCT04674228?
The interventions under investigation include: Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04674228?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04674228 being conducted?
This trial has 2 study locations across Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Adenomatous Polyposis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
RECRUITING
-
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
RECRUITING
-
Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
RECRUITING · NA
-
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RECRUITING · Phase 1
-
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
RECRUITING · NA
-
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.